Hematology TimesCHMP backs therapy for hemophilia ANovember 14, 2017ThrombosisPharmacyBleeding Disorders
Hematology TimesCHMP wants to expand use of BV to include CTCLNovember 14, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesCHMP recommends letermovir as CMV prophylaxisNovember 14, 2017PharmacyTransplantation
Hematology TimesCHMP recommends approval of romiplostim in kidsNovember 12, 2017AnemiaThrombosisPediatricsPharmacyBleeding Disorders
Hematology TimesDasatinib approved to treat kids with CMLNovember 11, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Hematology TimesFDA approves brentuximab vedotin for pcALCL, MFNovember 10, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFDA approves IV formulation of aprepitant for CINVNovember 10, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Hematology TimesFDA grants drug orphan designation for treatment of malariaNovember 9, 2017PharmacyRelated Issues
Hematology TimesEMA grants accelerated assessment to drug for AMLNovember 9, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFerric citrate approved to treat iron-deficiency anemiaNovember 8, 2017AnemiaPharmacy
Hematology TimesCancer drug costs increasing despite competitionNovember 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyAMLALLNon-Hodgkin Lymphoma
Hematology TimesFDA grants product breakthrough designation for MMNovember 3, 2017Multiple MyelomaPharmacy
Hematology TimesFDA approves drug to treat rel/ref MCLNovember 1, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
